Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019163 (
hepatitis B
)
38,309
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TEA domain (TEAD) transcription factors play an important role in hepatocellular carcinoma (HCC) development and progression by regulating the expression of a number of genes. However, the association of their genetic variations with HCC prognosis remains elusive. Seven potentially functional single nucleotide polymorphisms in
TEAD1
-
4
(rs2304733, rs10831923, rs12104362, rs3745305, rs11756089, rs2076173, rs7135838) were genotyped from 331
hepatitis B
virus positive HCC patients using the Sequenom MassARRAY iPLEX platform. The
TEAD3
rs2076173 C allele and rs11756089 T allele were identified as protective alleles as they were significantly associated with longer median overall survival time (MST). The T allele of rs2076173 was significantly associated with HCC survival independent of age, gender, smoking and drinking status, BCLC stage, and chemotherapy or TACE status (HR = 0.73, 95% CI = 0.56-0.93,
P
= 0.012). This protective effect was more prominent for patients who were non-drinkers (
P
for multiplicative interaction = 0.002). Patients had more than one of these protective alleles had significant longer MST of 19.25 months than those had none (MST=12.85 months, adjusted HR = 0.56, 95% CI = 0.33-0.95,
P
=0.030), especially for those non-drinkers (adjusted HR = 0.48, 95% CI = 0.32-0.74,
P
= 0.001). These findings suggested that rs2076173 and rs11756089 in
TEAD3
gene could serve as genetic markers for favorable survival in the Chinese HCC patients.
...
PMID:The prognostic impacts of
TEA domain (TEAD)
transcription factor polymorphisms in Chinese hepatocellular carcinoma patients. 2905 Feb 44